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Abstract: The application of nanoparticles has experienced a vertiginous growth, but their interaction
with food and medicinal plants in organisms, especially in the control of reproduction, remains
unresolved. We examined the influence of copper nanoparticles supported on titania (CuNPs/TiO2),
plant extracts (buckwheat (Fagopyrum esculentum) and vitex (Vitex agnus-castus)), phytochemicals
(rutin and apigenin), and their combination with CuNPs/TiO2 on ovarian cell functions, using
cultured porcine ovarian granulosa cells. Cell viability, proliferation (PCNA accumulation), apoptosis
(accumulation of bax), and hormones release (progesterone, testosterone, and 17β-estradiol) were
analyzed by the Trypan blue test, quantitative immunocytochemistry, and ELISA, respectively.
CuNPs/TiO2 increased cell viability, proliferation, apoptosis, and testosterone but not progesterone
release, and reduced the 17β-estradiol output. Plant extracts and components have similar stimulatory
action on ovarian cell functions as CuNPs/TiO2, but abated the majority of the CuNPs/TiO2 effects.
This study concludes that (1) CuNPs/TiO2 can directly stimulate ovarian cell functions, promoting
ovarian cell proliferation, apoptosis, turnover, viability, and steroid hormones release; (2) the plants
buckwheat and vitex, as well as rutin and apigenin, can promote some of these ovarian functions too;
and (3) these plant additives mitigate the CuNPs/TiO2’s activity, something that must be considered
when applied together.
Keywords: apoptosis; copper nanoparticles; hormones; buckwheat; vitex; rutin; apigenin; ovary;
phytochemicals; proliferation
1. Introduction
Nanotechnology and the applications of metal nanoparticles (i.e., particles with a
diameter < 100 nm) have rapidly developed in recent years [1–4]. In particular, nanoparticles of
the relatively cheap and abundant copper (CuNPs) have found multiple applications in diverse areas,
including catalysis [5] and materials science [6,7]. However, CuNPs have also been exploited for
disinfection purposes because of their effective antimicrobial properties, in medicinal chemistry or as
farm animal food additives [8–10]. Nevertheless, copper nanoparticles can adversely influence various
biological processes [11–13] and produce some toxicological effects on individual organisms [14].
Assays conducted on rodents proved the ability of both bulk copper and CuNPs to diminish the
levels of blood gonadal and gonadotropin steroid hormones to cause degenerative alterations in gonads,
ovarian follicular atresia, and to inhibit gamete and embryogenesis [15–17]. This detrimental behavior
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could be attributed to the ease of CuNPs to suppress the function of some antioxidative enzymes and
to produce ovarian cell apoptosis [16]. Other surveys, however, did not report any unfavorable effect of
CuNPs on various ovarian follicles of mice [15] and pregnancy [17]. Some studies revealed that copper
can have an important role in stimulating porcine pituitary gonadotropin secretion [15], on the ovulation
rate [18], release of insulin-like growth factor I and progesterone, and on the suppressed apoptosis and
proliferation in cultured granulosa cells [15,19]. Recent in vitro studies demonstrated both positive and
adverse effects of various unsupported and supported CuNPs on cell viability, proliferation, apoptosis,
and steroid hormones release in porcine ovarian granulosa cells [20]. Therefore, it is desirable to
synthesize proper CuNPs that can be applied with minimal toxic effects. Moreover, some CuNPs with
stimulatory influence on reproductive processes could be useful as novel biostimulators of reproduction
and, therefore, in animal production, biotechnology, and assisted reproduction.
We have been involved in the development of methods to prepare metal nanoparticles [21],
copper nanoparticles among them [22], which have found application as chemical catalysts either
unsupported [23] or supported on a variety of inorganic supports, including zeolite Y [24], charcoal [25],
and titania [26]. A previous comparison of CuNPs of different size, morphology, and inorganic support
enabled us [20] to identify CuNPs supported on titania nanopowder (CuNPs/TiO2) as a nanoparticle
combination with a potent direct effect on ovarian cells.
On the other hand, medicinal plants have been used in traditional medicine for centuries. That is
why there is a general upsurge of interest in the application of plant extracts to prevent or treat manifold
diseases [27–30]. It is known that some medicinal plants or their isolated chemical components (i.e.,
phytochemicals) are able to affect reproduction. They can be administered instead or in addition
to classical pharmacological drugs [31–33], though some interference between the plant and the
pharmacological preparation in their effect on female reproduction is possible [34].
In this context, buckwheat (Fagopyrum esculentum) is a medicinal and food plant containing a large
variety of polyphenolic antioxidants (including rutin and quercetin) with numerous health benefits [35],
the action of which on reproductive processes remains, however, unknown. Vitex (Vitex agnus-castus) is
another potential regulator of reproduction and health. The presence of antioxidants and phytoestrogens
in vitex makes it useful for the treatment of polycystic ovarian syndrome and the restoration of sex steroid
release and estrous cycle [36–38], for the therapy of premenstrual and postmenstrual syndromes [39,40]
and as a remedy for infertility [39]. Due to its ability to promote apoptosis, it can be also beneficial for
the prevention and cure of cancer [41,42].
The main biological effects of medicinal and food plants are related to the presence of polyphenols
with antioxidant and phytoestrogen activity. One of these polyphenols is the flavonoid rutin, which is
able to promote bone cell proliferation [43]. It can ameliorate testicular cell apoptosis, damage of
spermatogenesis, and the reduction of spermatogenesis induced by ischemia-reperfusion injury [44] and
restraint [45] and oxidative [46] stress. Rutin was able to prevent also the symptoms of polycystic ovarian
syndrome [47]. Another flavonoid-type phytoestrogen, apigenin, is able to suppress proliferation
and viability, and to promote oxidative stress and apoptosis in non-ovarian [48,49] and ovarian [50]
cancer cells. It can restore ovarian folliculogenesis, ovulation, and steroidogenesis during polycystic
ovarian syndrome [51]. Furthermore, apigenin was able to prevent ovarian damage induced by
ischemia-reperfusion injury [52].
The available literature demonstrates the therapeutic potential of the aforementioned plants
and phytochemicals in the treatment of some reproductive disorders. However, there is no available
information concerning their action, for instance, by their routinely daily intake, on healthy reproductive
systems. Furthermore, CuNPs, medicinal/food plants and phytochemicals can be applied to regulate
reproduction and reproductive disorders, but their functional interrelationships within the ovary by
their joint application have not been elucidated yet.
Our present study is aimed to understand whether basic ovarian cell functions can or cannot be
directly affected by: (a) CuNPs/TiO2, (b) some medicinal/food plants (buckwheat and vitex) and/or
their polyphenol constituents (rutin and apigenin), and (c) the combination of CuNPs/TiO2 and
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the plant/phytochemical. For this purpose, we compared the influence of CuNPs/TiO2 (0, 1, 10,
or 100 µg/mL), buckwheat, vitex, rutin, and apigenin (10 µg/mL) when given individually and when
CuNPs/TiO2 was combined with plant additives. We compared the activity of these treatments
on cultured porcine ovarian granulosa cells by studying cell viability, the accumulation of bax (a
cytoplasmic apoptosis marker) [53,54], PCNA (a proliferation marker) [55], and the release of the
steroid hormones testosterone, progesterone, and 17β-estradiol, the regulators and markers of ovarian
cell functions [56]. This survey reveals that CuNPs/TiO2 can boost some of the aforementioned ovarian
cell functions, as buckwheat, vitex, rutin, and apigenin also do. However, the activity CuNPs/TiO2 is
significantly depleted in the presence of these plant additives.
2. Materials and Methods
2.1. Preparation of Copper Nanoparticles Supported on Titania (CuNPs/TiO2)
The methodology of Alonso’s group [21] was applied for the synthesis of CuNPs/TiO2. In this
protocol, a suspension was prepared in a Schlenk flask containing lithium powder (14 mg, 2 mmol,
Medalchemy S.L.) and 4,4′-di-tert-butylbiphenyl (27 mg, 0.1 mmol; DTBB, Sigma-Aldrich, St. Louis,
MO, USA) in dry tetrahydrofuran as a solvent (THF, 20 mL) under argon at room temperature.
Anhydrous CuCl2 (134 mg, 1.0 mmol; 97%, Sigma-Aldrich, St. Louis, MO, USA) was added to this
suspension. The initially formed dark-green reaction mixture changed to black, as a result of the
formation of CuNPs. Then, additional dry THF (18 mL) and TiO2 (1.28 g, titania anatase nanopowder,
Alfa Aesar, Ward Hill, MA, USA) were added to the above suspension. The reaction mixture was
stirred at room temperature for 1 h, followed by filtration and drying under air.
2.2. Isolation and Culture of Granulosa Cells
The granulosa cells were isolated from the ovaries of non-cycling pubertal gilts (180 days
age, approximately), and were processed and cultured as previously described [57–61]. Briefly,
the collected granulosa cells (at 106 cells/mL concentration) were precultured in sterile Dulbecco’s
modified Eagle medium (DMEM)/F12 1:1, containing 10% fetal calf serum (both from BioWhittakerTM,
Verviers, Belgium) and 1% antibiotic-antimycotic solution (Sigma-Aldrich, St. Louis, MO, USA) in
16-well (200 µL/well) chamber slides (Nunc Inc., International, Naperville, IL, USA) during 3–4 days.
Buckwheat (Fagopyrum esculentum), vitex (Vitex agnus-castus; both from F-DENTAL Hodonín s.r.o.,
Hodonín, Czech Republic), rutin (WallMark, a.s., Trˇinec, Czech Republic), and apigenin (Merck KGaA,
Darmstadt, Germany) were commercially available. The plants were minced for 2 min in a coffee mill.
Thereafter, either the plant powder or the plant components apigenin and rutin were dissolved in
50 µL of DMSO in order to make stock solutions of 1 mg/mL. These stock solutions were dissolved
in the culture medium immediately before their addition to the cells, in such a way that the final
concentration of DMSO did not exceed 0.001%. Previous studies revealed no substantial effects of
0.001% DMSO on ovarian cell function and viability. Controls included ovarian cells cultured in the
incubation medium (with 0.001% DMSO) without treatment and the medium incubated without cells
(blank control).
The original medium was replaced with one of the same composition without and with
CuNPs/TiO2, at the concentrations of 0, 1, 10, or 100 µg/mL, with buckwheat, vitex, rutin, and apigenin,
each at 10 µg/mL. In addition, CuNPs/TiO2 (0, 1, 10, or 100 µg/mL) was combined with each of the
plant additives listed above (10 µg/mL). In this case, the plant additive was first added to the cell
culture and, after 10–15 min, CuNPs/TiO2 was added to the resulting medium. These doses correspond
to those of CuNPs that can be ingested and that have been applied in previous animal experiments,
both in vivo and in vitro [20,58–61]. The dose of the plant additives was selected on the basis of the
doses used in the corresponding previous in vitro experiments [41,43,45,49,50]. These substances were
dissolved in the culture medium just before their addition to the cells. The cell and the incubation
medium were analyzed after two days of culture.
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2.3. Cell Viability Test
The Trypan blue exclusion test was used to evaluate the cell viability, according to Strober [62].
Succinctly, removal of the medium from the culture plates was done after incubating the granulosa
cells. Then, the Trypan blue staining (Sigma-Aldrich, Hamburg, Germany) was applied to the cell
monolayer for 15 min. After removal of this dye, the plates were subjected to washing (twice with
the physiological solution) and to microscopic inspection (magnification: 400×). The ratio of dead
(stained) cells to the total cell count was calculated.
2.4. Immunocytochemical Analysis of Proliferation and Apoptosis Markers
Immunocytochemistry was used to detect the presence of PCNA and bax in the cells, as described
previously [19,20,57–61], by means of primary monoclonal antibodies against PCNA and bax (dilution
1:500; from Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), secondary swine antibodies against
mouse IgG labeled with horseradish peroxidase (dilution 1:1000; Servac, Prague, Czech Republic) and
visualized by DAB-substrate staining (Roche Diagnostics GmbH, Manheim, Germany). In some cases,
the assay was validated by these primary antibodies and secondary polyclonal goat antibodies against
mouse IgGs, labeled with fluorescein isothiocyanate (FITC, dilution 1:1000; Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA; Figure 1). The negative controls were performed with cells processed
without the primary or secondary antibody. The cells were inspected with the aid of a light and a
fluorescence microscope (Leica GmbH, Wetzlar, Germany). The cells showing a signal larger than that
of the levels of the background negative controls were considered positive. The percentage of cells
containing a visible signal–marker of PCNA and bax was calculated relative to the total cell number.
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2.5. Immunoassay of Hormones
Progesterone, testosterone, and 17β-estradiol concentrations were determined from 25 µL aliquots
of the incubation medium through the enzyme-linked immunosorbent assay (ELISA), utilizing
ELISA’s kits (LDN Immunoassays and Services, Nodhorn, Germany), following the instructions of the
manufacturer. The details of the assay were reported previously [20]. Validation of all the assays was
accomplished by dilution tests of culture medium samples.
2.6. Statistical Analysis
Each experiment was repeated thrice using ovaries from different animals (10–15 ovaries per
experiment). In some experiments, all the treatments were tested at once, in other experiments
the effects of only part of the additives were investigated (for example, CuNPs/TiO2 alone and in
combination with rutin or apigenin). The presented data are the summarized results obtained from,
at least, three independent experiments. Each group of experiments was represented by four culture
wells. Immunocytochemical and viability tests were performed on, at least, 1000 cells per group.
By using ELISA, blank control values were subtracted from those determined in the cell-conditioned
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medium in order to exclude any non-specific background (<13% of the total values). Secretion rates
were calculated for 106 cells/day. Differences between groups were evaluated using the Shapiro–Wilk’s
normality and Student’s t-tests and Sigma Plot 11.0 (Systat Software, GmbH, Erkhart, Germany).
The data was expressed as the mean ± standard error of mean (SEM). Differences were considered
statistically significant at p ≤ 0.05.
3. Results
The solid composed of copper nanoparticles on titania (CuNPs/TiO2) was characterized by
transmission electron microscopy (TEM), showing well dispersed spherical CuNPs of an 0.98 ± 0.42 nm
average size (Figure 2). The copper loading was determined to be 1.9 wt% by inductively coupled
plasma optical emission spectroscopy (ICP-OES). The oxidation state of the copper species was analyzed
by X-ray photoelectron spectroscopy (XPS), denoting the presence of both Cu(I) and Cu(II) oxide
because of the exposure of the nanoparticles to air [20].
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Figure 2. Transmission el ctron mi py micrograph of CuNPs/TiO2.
The cells in all the groups were viable, contai arkers of a ptosis (bax) and proliferation
(PCNA), and secreted substantial amounts of the steroids progesterone, testosterone, and 17β-estradiol.
The addition of CuNPs/TiO2, buckwheat, vitex, rutin, and apigenin was able to alter these parameters.
CuNPs/TiO2, when added alone at the doses of 10 or 100 µg/mL, increased cell viability
(Figures 3A, 4A, 5A and 6A). It also promoted PCNA accumulation (at all the doses added
(Figures 3B and 4B) or at a dose of 1 µg/mL (Figure 5B) or 10 and 100 µg/mL (Figure 6B)). Accumulation
of bax was augmented after the addition of CuNPs/TiO2 (at 10 and 100 µg/mL, Figures 3C, 4C and 5C),
though in one series of experiments CuNPs/TiO2 did not affect this marker of apoptosis (Figure 6C).
CuNPs/TiO2 did not affect progesterone release (Figures 3D, 4D and 6D) except in one series of
experiments, where CuNPs/TiO2 inhibited it (at the dose of 100 µg/mL, Figure 5D). The testosterone
output rose after the addition of CuNPs/TiO2 (at the dose of 10 µ / , Figures 3E, 4E, 5E and 6E).
17β-Estradiol release was promoted by CuNPs/TiO2 (at 10 and 100 µg/mL, Figures 3F, 4F, 5F and 6F).
Buckwheat, when added alone, enhanced cell viability (Figure 3A, see CuNPs/TiO2 at the
dose of 0 µg/mL) and accumulation of bax (Figure 3C), whereas it lowered the testosterone release
(Figure 3E). No significant buckwheat influence on PCNA (Figure 3B), progesterone (Figure 3D),
and 17β-estradiol (Figure 3F) was observed. The influence of CuNPs/TiO2 on cell viability (Figure 3A),
PCNA/proliferation (Figure 3B), bax/apoptosis (Figure 3C), the r lease of testosterone (F gure 3E),
and 17β-estradiol (Figure 3F) as significantly lower in the pr se c of buckwheat than in its absence.
Moreover, buckwheat not only prevented but also even inverted the action of CuNPs/TiO2 on
bax–CuNPs/TiO2 (at 100 µg/mL). The presence of buckwheat did not promote but inhibited bax
accumulation (Figure 3C). The presence of buckwheat did not substantially modify the CuNPs/TiO2 (1
or 10 µg/mL) effect on the progesterone release, but CuNPs/TiO2 added at a dose of 100 µg/mL failed
to promote progesterone output in the presence of buckwheat (Figure 3D).
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untreated with CuNPs/TiO2.
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Figure 5. Effect of s/ i 2 (0, 1, 10, or 100 µg/mL) alone (white bars) and in combination
with rutin (10 µg/mL; black bars) on the viability (Trypan blu exclusion assays) (A), proliferation
(expression of proliferating cell nuclear antig , , antitative immunocytochemistry) (B),
apo tosis (expression of bax, quantitative i e istry) (C), and secretion of progesterone
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Vitex, when given alone, increased cell viability (Figure 4A), PCNA (Figure 4B) and bax (Figure 4C)
accumulation, and the release of 17β-estradiol (Figure 4F) but not of progesterone (Figure 4D) or
testosterone (Figure 4E). Furthermore, vitex prevented the stimulatory action of CuNPs/TiO2 on
cell viability (Figure 4A), the accumulation of PCNA (Figure 4B) and bax (Figure 4C), and on the
testosterone release (Figure 4E). Moreover, it changed the stimulatory action of CuNPs/TiO2 on bax
(Figure 4C) and 17β-estradiol (Figure 4F) to an inhibitory one. Vitex did not modify the CuNPs/TiO2
influence on the progesterone output (Figure 4D).
Rutin addition intensified cell viability (Figure 5A), testosterone (Figure 5E), and 17β-estradiol
(Figure 5E) release, but not PCNA (Figure 5B) or bax (Figure 5C) accumulation or the release of
progesterone (Figure 5D). Furthermore, it arrested and even inverted the CuNPs/TiO2 activity on cell
viability (Figure 5A), progesterone (Figure 5C), testosterone (Figure 5E), or 17β-estradiol (Figure 5F),
but not on PCNA (Figure 5B) or bax (Figure 5C) accumulation.
Apigenin promoted cell viability (Figure 6A), PCNA accumulation (Figure 6B), and the secretion
of testosterone (Figure 6E) and 17β-estradiol (Figure 6F), whereas it shortened the progesterone release
(Figure 6D) and had no effect on the accumulation of bax (Figure 6C). In the presence of apigenin,
CuNPs/TiO2 lost its ability to promote cell viability (Figure 6A), accumulation of PCNA (Figure 6B)
and the release of testosterone (Figure 6E), but not to boost the accumulation of bax (Figure 6C) or the
release of 17β-estradiol (Figure 6F). Moreover, CuNPs/TiO2 could inhibit the progesterone release in
the presence of apigenin (Figure 6D).
4. Discussion
The formation of a monolayer, the high cell viability, the presence of intracellular markers of
proliferation and apoptosis and the production of steroid hormones denote that the porcine granulosa
cells tested were in good condition and adequate for the analyses and testing of the effects of CuNPs/TiO2,
plant extracts and phytochemicals. The character of the changes induced by these additives and their
combinations are summarized in Table 1. Although the percentage of changes varied between the
experiments, all the experiments demonstrated a similar pattern of an additive effect on ovarian cells.
The performed studies demonstrated the stimulatory influence of CuNPs/TiO2 on five out of the
six measured ovarian cell functions; only one parameter remained unchanged. These observations
suggest the absence of toxicity of copper nanoparticles supported on titania, in contrast to a variety of
other copper nanoparticles [11,12,14]. Moreover, these results are in line with our previous observation
about the stimulatory activity of this type of nanoparticles on ovarian cell functions. The mechanism
of this effect and the functional interrelationships between the measured parameters require further
elucidation. Nevertheless, CuNPs/TiO2 induced an increase of both, proliferation and cytoplasmic
apoptosis, suggesting the ability of these nanoparticles to promote ovarian cell turnover. In addition to
this, CuNPs/TiO2 also increased cell viability, a result that could be rationalized by the dominance
of cell proliferation over cell apoptosis. Intensified apoptosis could be a result of the augmented
release of testosterone, a promoter of ovarian follicular atresia and cytoplasmic apoptosis. Finally,
the growth in proliferation might be due to a larger production of 17β-estradiol, which is a known
promoter of cell proliferation and viability [56]. In any case, it must be taken into account that cell
viability can be affected not only by cytoplasmic apoptosis (induced by bax [53,54]) but, alternatively,
by nuclear apoptosis associated with nuclear DNA fragmentation [63,64], which has not been analyzed
herein. It has been demonstrated that some regulators can induce the opposite changes in cytoplasmic
and nuclear apoptosis in porcine granulosa cells [57]. Therefore, it cannot be completely excluded
that CuNPs/TiO2 might suppress nuclear apoptosis, which, together with increased proliferation,
could boost cell viability. If the stimulatory action of CuNPs/TiO2 on the ovary occurred in vivo
too, the potential application of CuNPs/TiO2 as a safe replacement of toxic CuNPs and a novel
biostimulating agent of reproductive processes in animals and humans cannot be disregarded.
Nanomaterials 2020, 10, 1859 9 of 14
Table 1. Character of the effect of CuNPs/TiO2, buckwheat, vitex, rutin, and apigenin, given alone,
on cultured porcine ovarian granulosa cell functions, and the ability of buckwheat, vitex, rutin,
and apigenin to modify the activity of CuNPs/TiO2 a.
Additive b Cell
Viability
Proliferation
(PCNA)
Apoptosis
(Bax)
Release of Steroid Hormones
Progesterone Testosterone Estradiol
CuNPs/TiO2 + + + 0 + +
Buckwheat + 0 + 0 – 0
Buckwheat and
CuNPs/TiO2
– – – – – –
Vitex + + + 0 0 +
Vitex and
CuNPs/TiO2
– – – 0 – –
Rutin + 0 0 0 + +
Rutin and
CuNPs/TiO2
– 0 0 – – –
Apigenin + + 0 – + +
Apigenin and
CuNPs/TiO2
– – 0 – – 0
a Type of effect: stimulation (+), no effect (0), and inhibition (–). b Concentration of CuNPs/TiO2: 1, 10, or 100 µg/mL
and concentration of buckwheat, vitex, rutin, and apigenin: 10 µg/mL.
The performed studies demonstrate the direct influence of some plant extracts and their
phytochemicals on ovarian cell functions. The ability of buckwheat to enhance viability and
apoptosis of cultured cells is the first evidence on the direct action of buckwheat on ovarian functions.
The mechanisms of these buckwheat effects remain unknown. The stimulatory action of vitex on ovarian
cell viability, proliferation, apoptosis, and 17β-estradiol release is concordant with previous indications
on its ability to increase ovarian cell apoptosis [41,42] and steroidogenesis [36–40]. Furthermore,
there is the first evidence on the capability of vitex to promote ovarian cell proliferation, resulting in
cell turnover and viability. These effects explain the stimulatory and therapeutic action of vitex on
some ovarian functions reported previously [36–40].
The tested phytochemicals exhibit stimulatory activity on some ovarian cell functions similar to the
stimulatory effects shown by the whole plant extracts. For example, in our experiments, rutin boosted
cell viability and the release of testosterone and 17β-estradiol. It cannot be ruled out that the cell viability
increase could be attributed to the increased release of the anti-atretic hormone 17β-estradiol [62], though
the mechanism of rutin’s role is worthy of further studies. The present results are the first evidence
about the direct stimulatory activity of rutin on healthy ovarian cells. This activity is in agreement
with the therapeutic effect of this polyphenol on an ovary that suffered from ischemia-reperfusion
injury [44], restraint [45], and polycystic ovarian syndrome [47], reported previously.
Another polyphenolic phytochemical, apigenin, also manifested stimulatory behavior on several
ovarian functions (viability, proliferation, testosterone, and 17β-estradiol release), albeit it suppressed
the progesterone output. The promotion of cell viability by apigenin can be explained by its capacity
to promote ovarian cell proliferation, but not apoptosis, i.e., to change the proliferation/apoptosis
rate. This effect could be attributed to the increased secretion of 17β-estradiol, which is considered
an inducer of ovarian cell proliferation. What is more, the increase of cell viability, proliferation
and release of 17β-estradiol, and the decrease of progesterone release suggest that apigenin could
be a natural stimulating agent of ovarian follicle survival, growth, and an inhibitor of follicular
luteinization and atresia, which are under control of these hormones [56]. This is the first proof of the
apigenin activity on healthy ovarian cells, which supports the potential benefits of apigenin-containing
products for the promotion of animal and human reproductive processes. Furthermore, the changes
induced by apigenin in healthy ovarian cells, observed in the present experiments, explain its ability
to promote ovarian functions during polycystic ovarian syndrome [51] and ischemia-reperfusion
injury [52]. Moreover, the ability of apigenin to induce apoptosis and to reduce the viability of cancer
cells, observed previously [50], but not those in healthy ovarian cells (in our experiments), sustains a
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potential applicability of apigenin for the selective suppression of cancer and for the support of healthy
cells in the ovary.
The similar activity found for some plant extracts and plant components on some ovarian cell
parameters might indicate, in principle, that the plants tested could affect some ovarian functions
because of the presence of the phytochemicals rutin and apigenin among their components. However,
only a small proportion of their effects was found to be similar, probably because of the participation
of other molecules or molecule complexes. The plants effect could not be explained by the presence of
another ubiquitous polyphenolic phytochemical, quercetin, because its suppressive action on all the
ovarian functions reported previously [58–61] is opposed to that observed for buckwheat and vitex in
the present study. Therefore, it seems that rutin, apigenin, and quercetin cannot explain the action of
buckwheat or vitex on ovarian cells, and that these polyphenols cannot replace the treatment with the
whole plant extract.
Interestingly, the plants and the polyphenolic flavonoids tested were able not only to affect basic
ovarian cell functions, but also to diminish the stimulatory action of CuNPs/TiO2 on these functions.
In particular, buckwheat prevented the action of CuNPs/TiO2 on all measured indexes and vitex
inhibited the activity of CuNPs/TiO2 in five out of the six measured parameters, whereas rutin and
apigenin did the same in four out of six parameters. None of the plant additives promoted any
CuNPs/TiO2 effect, which might indicate that the tested plant additives could oppose the action of
CuNPs/TiO2. Based on our experience on CuNPs [23–26], we know that their catalytic activity in
chemical reactions can be depleted or even completely blocked by their interaction with hydroxyl
groups present in organic molecules. Taking into account that plant extracts, as well as rutin and
apigenin, are rich in hydroxyl groups, because of the presence of carbohydrate and/or phenolic units,
their binding to the surface of the CuNPs could passivate it, with the concomitant reduction of CuNPs’
bioactivity. This behavior could have some health consequences and should be taken into account in
view of some potential medical applications, avoiding their joint prescription. Moreover, it cannot be
discarded that a daily diet containing these plants and/or their components could reduce the application
efficiency of CuNPs/TiO2.
The performed experiments did not address all the possible questions concerning the mechanisms
of action and interrelationships of the different ovarian regulators. Nevertheless, they show (1) that
CuNPs/TiO2 could directly stimulate ovarian cell functions; (2) that CuNPs/TiO2 could positively affect
ovarian cell proliferation, apoptosis, turnover, viability, and steroid hormones release; (3) that the
plants buckwheat and vitex, and the phytochemicals rutin and apigenin, could promote some of these
ovarian functions too; and (4) that these plant additives could not promote but abate the action of
CuNPs/TiO2, what must be taken into account for their potential application.
Therefore, given the ability of food and medicinal plants and their polyphenolic constituents to
suppress the activity of CuNPs, to intake CuNPs and these plants or plant components jointly seems
unadvisable concerning the ovarian functions. However, this interaction can be beneficial to prevent
the potential noxious effect, when accidentally exposed to CuNPs, on other types of cells or organs.
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